Clinical Trials Logo

Filter by:
NCT ID: NCT03776435 Recruiting - Appendicitis Clinical Trials

CT Carcinogenic Risk in Patients With Appendicitis

Start date: January 15, 2018
Phase:
Study type: Observational

The purpose of this study is to compare the incidence rate of cancer between CT-exposed and CT-unexposed group in patients who underwent appendectomy in South Korea.

NCT ID: NCT03776266 Completed - Clinical trials for Percutaneous Coronary Intervention

The Long-term Clinical Outcomes and Patterns of Transfusion in Patients Undergoing Percutaneous Coronary Intervention

TFPCI
Start date: October 5, 2018
Phase:
Study type: Observational

A nationwide retrospective cohort study. To investigate the long-term patterns of transfusion and clinical outcomes of patients undergoing PCI.

NCT ID: NCT03775837 Recruiting - Liver Diseases Clinical Trials

Effect of Panax Ginseng C.A. Mey Extract on Liver Function in Adults

Start date: December 1, 2018
Phase: N/A
Study type: Interventional

The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Panax Ginseng C.A. Mey Extract on liver function in adults for 8 weeks.

NCT ID: NCT03775733 Recruiting - Hyperglycemia Clinical Trials

Efficacy and Safety of Hydrolysed Red Ginseng Extract on Improvement of Hyperglycemia

Start date: December 30, 2018
Phase: N/A
Study type: Interventional

This study was conducted to investigate the effects of daily supplementation of hydrolysed red ginseng extract on improvement of Hyperglycemia.

NCT ID: NCT03775629 Recruiting - Healthy Clinical Trials

Drug-Drug Interaction Study of "CG100650" in Healthy Volunteers

Start date: December 1, 2018
Phase: Phase 1
Study type: Interventional

This is a randomized, open-label, multiple-dose, parallel, Phase 1 study to compare the pharmacokinetics and to evaluate Drug-Drug Interaction of "CG100650" in healthy volunteers.

NCT ID: NCT03775603 Not yet recruiting - Clinical trials for Neuromuscular Blockade

Comparison of TOFscan and TOF-Watch SX in Pediatric Neuromuscular Function Recovery

Start date: January 10, 2019
Phase:
Study type: Observational

Comparison of TOFscan and TOF-Watch SX for monitoring of neuromuscular blockade function in children

NCT ID: NCT03775486 Not yet recruiting - Clinical trials for Non-small Cell Lung Cancer NSCLC

Study of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION)

ORION
Start date: December 11, 2018
Phase: Phase 2
Study type: Interventional

This is a randomized, double-blind, multi-center, global Phase II study to determine the efficacy and safety of Durvalumab plus Olaparib combination therapy compared with Durvalumab monotherapy as maintenance therapy in patients whose disease has not progressed following Standard of Care (SoC) platinum-based chemotherapy with Durvalumab as first-line treatment in patients with Stage IV non small-cell lung cancer (NSCLC) with tumors that lack activating epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) fusions.

NCT ID: NCT03774381 Recruiting - Obesity Clinical Trials

Effect of Bifidobacterium Breve B-3 on Body Fat in Obese Adults

Start date: September 1, 2018
Phase: N/A
Study type: Interventional

Comparison of a randomized, double-blind, and control-group study for the effect of oral ingestion of Bifidobacterium breve B-3 on body fat reduction in obese adults

NCT ID: NCT03774355 Not yet recruiting - Healthy Clinical Trials

Study to Compare Safety and Pharmacokinetics of "CG1801" and "CGL1802" in Healthy Volunteers

Start date: December 17, 2018
Phase: Phase 1
Study type: Interventional

The objective of this open-label, randomized, 2*2 crossover study is to compare the safety and Pharmacokinetics CG1801 and CGL1802 in Healthy Volunteers.

NCT ID: NCT03773315 Recruiting - Dyslipidemias Clinical Trials

Ulmus Macrocarpa Hance Extract and Lipid Profile

Start date: December 1, 2018
Phase: N/A
Study type: Interventional

The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of the Ulmus Macrocarpa Hance extract on lipid profile in adults with dyslipidemia for 12 weeks.